<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Little is known about the role of cyclooxygenase (COX)-2 in <z:hpo ids='HP_0002020'>gastroesophageal reflux disease</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>) and the development of Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>The objectives of this study were to further analyze COX-2 mRNA expression in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> compared to <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (BE) and Barrett's <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (BC) </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Tissue samples from 110 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> (n = 43), BE (n = 20), and BC (n = 47) were obtained in routine upper GI endoscopy </plain></SENT>
<SENT sid="3" pm="."><plain>Expression levels of COX-2 were measured by quantitative real-time reverse trancriptase polymerase chain reaction (RT-PCR) </plain></SENT>
<SENT sid="4" pm="."><plain>Also, 24-h pH monitoring was performed in <z:hpo ids='HP_0000001'>all</z:hpo> patients of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> study group and the DeMeester composite score was used to match COX-2 mRNA expression with the severity of acid exposure in the lower esophagus </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: COX-2 mRNA is progressively upregulated within the <z:mpath ids='MPATH_160'>metaplasia</z:mpath>-<z:mpath ids='MPATH_589'>dysplasia</z:mpath>-<z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (<z:chebi fb="14" ids="32506">MDA</z:chebi>) sequence (p = 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>COX-2 levels of the squamous epithelium in the distal esophagus from patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> and a pathologic mean DeMeester score (&gt;14.72) were significantly higher than in patients with <z:mpath ids='MPATH_458'>normal</z:mpath> DeMeester scores (p = 0.01) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: In summary our findings suggest that alterations in COX-2 mRNA expression occur independently of endoscopic or histologic signs of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> in the acid-exposed squamous epithelium of the distal esophagus </plain></SENT>
<SENT sid="8" pm="."><plain>However, this early COX-2 increase in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> is further upregulated within the <z:chebi fb="14" ids="32506">MDA</z:chebi> sequence for yet unknown reasons </plain></SENT>
</text></document>